-
Joseph R. Berger, MD
Co-chair
University of Pennsylvania
Philadelphia, Pennsylvania
Joseph R. Berger, MD
Professor of Neurology and Chief of the MS Division
Department of Neurology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Joseph R. Berger, MD, is professor and associate chief of the MS Division in the Department of Neurology at the Perelman School of Medicine of the University of Pennsylvania in Philadelphia. Dr. Berger is a summa cum laude graduate of the Penn State-Jefferson Premedical-Medical Program and a member of Alpha Omega Alpha. He completed his residency in internal medicine at Georgetown University Hospital, and his neurology residency at the University of Miami School of Medicine prior to joining the faculty of the University of Miami School of Medicine with appointments in both the Departments of Neurology and Medicine. At that institution, he held the Whigham-Berger Endowed Chair for the study of the neurological complications of HIV/AIDS. Subsequently, Dr. Berger was the Ruth L. Works Professor of Neurology at the University of Kentucky College of Medicine, where he served as Chairman of Neurology for 18 years and was the founder and director of the MS Clinic. He is a fellow of the American Academy of Neurology, the American College of Physicians, and the American Neurological Association. Dr. Berger’s research interests include the neurological complications of HIV/AIDS, PML, MS, and other inflammatory disorders of the brain, and he is currently studying MS disease-modifying drugs and JCV expression during treatment with MS disease-modifying drugs. Dr. Berger has been the recipient of numerous grants to support his research. He has published more than 250 refereed papers, more than 100 chapters, and has edited 4 textbooks. He has been an associate editor for the Journal of NeuroVirology and has served or is serving on several other editorial boards including the journal MS and Related Disorders.
-
Fred D. Lublin, MD
Co-chair
Icahn School of Medicine at Mount Sinai
New York, New York
Fred D. Lublin, MD
Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center
for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, New York
Fred D. Lublin, MD, is the Saunders Family Professor of Neurology at the Icahn School of Medicine at Mount Sinai and director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at that institution.
Dr. Lublin received his medical degree from Jefferson Medical College in Philadelphia. He completed his internship in internal medicine at Bronx Municipal Hospital, Albert Einstein Medical Center, and his residency at New York Hospital, Cornell Medical Center.
As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He has been involved in both basic science and clinical research. He and his colleagues were among the first in the country involved in studies of Interferon beta-1b, which was approved by the Food and Drug Administration (FDA) in 1993 to treat the relapsing-remitting form of multiple sclerosis. Dr. Lublin is currently involved in several new clinical research protocols on promising agents for treating various aspects of MS. He was the principal investigator of the National Institutes of Health-sponsored multicenter Combination Therapy Study in Multiple Sclerosis.
Dr. Lublin was chairman of the National MS Society (USA) advisory committee on clinical trials of new drugs in multiple sclerosis and the National Multiple Sclerosis Society’s Research Programs Advisory Committee. He is a member of the International Medical and Scientific Board of the Multiple Sclerosis International Federation.
Dr. Lublin and his colleagues at the National MS Society have redefined the clinical course definitions of MS, updated in 2014, and he is a member of the international panel that periodically redefines the diagnostic criteria for MS. He has chaired a task force on the ethics of placebo-controlled trials in MS. Dr. Lublin is co-chair of the National Institute of Neurological Diseases and Stroke MS Common Data Elements committee and a member of their steering committee. He was a member of the World Health Organization Advisory Group for the Revision of ICD-10 Diseases of the Nervous System working group on demyelinating diseases of the central nervous system.
Dr. Lublin has published numerous scientific articles and was a founding editor in chief of the journal Multiple Sclerosis and Related Disorders. He belongs to a number of professional societies and advisory boards and has served as a consultant to the National Institutes of Health and to many pharmaceutical and biotech companies in all phases of new drug development and in preparation for presentation to the FDA and its advisory panels.
-
Bruce A. Cohen, MD
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Bruce A. Cohen, MD
Professor, Davee Department of Neurology & Clinical Neurosciences
Director, Northwestern Comprehensive MS Program
Northwestern University Feinberg School of Medicine
Northwestern Medicine
Chicago, Illinois
Bruce A. Cohen, MD, is a professor of neurology in the Davee Department of Neurology and Clinical Neurosciences at Northwestern University Feinberg School of Medicine in Chicago. Dr. Cohen cofounded the Northwestern Comprehensive MS program in 1986.
He received his medical degree from the University of Illinois, Abraham Lincoln School of Medicine, Chicago, and completed residencies in internal medicine at Lutheran General Hospital, Park Ridge, Illinois, and neurology at McGaw Medical Center, Northwestern University. He is board certified in neurology and internal medicine.
Dr. Cohen has conducted research in the clinical aspects of MS and neurologic complications of HIV/AIDS infection. He is a fellow of the American Academy of Neurology, the American Neurological Association and the American College of Physicians. He is a past chair of the Multiple Sclerosis section of the American Academy of Neurology, and of the National Medical Advisory Committee of the National Multiple Sclerosis Society.
-
Patricia K. Coyle, MD
Stony Brook University Medical Center
Stony Brook, New York
Patricia K. Coyle, MD, FAAN, FANA
Professor and Interim Chair
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York
Patricia K. Coyle, MD, FAAN, FANA, is interim chair and professor of neurology, as well as director of the Stony Brook Multiple Sclerosis (MS) Comprehensive Care Center. She earned her medical degree and completed her residency in neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland, where she also completed a fellowship in neuroimmunology and neurovirology. Her areas of expertise include MS, neuroimmunology, and neurologic infectious disease (in particular, Lyme disease).
Dr. Coyle has held multiple leadership positions at the American Board of Psychiatry and Neurology, the American Academy of Neurology, the American Neurological Association, and the National MS Society. She has served as an adviser to the FDA and the National Academy of Medicine (formerly the Institute of Medicine). Dr. Coyle has received research funding from the NIH and the National MS Society, and is actively engaged in studies to understand and treat neurological diseases.
-
Stephen Krieger, MD
Mount Sinai School of Medicine
New York, New York
Stephen Krieger, MD
Associate Professor of Neurology
Department of Neurology
Icahn School of Medicine at Mount Sinai
Attending Neurologist, Corinne Goldsmith
Dickinson Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, New York
Stephen Krieger, MD, is an associate professor of neurology at Mount Sinai Hospital, New York, where he served as the residency program director for 10 years through 2019. He received his MD degree from Yale University School of Medicine. He joined the Corinne Goldsmith Dickinson Center (CGDC) for Multiple Sclerosis at Mount Sinai as a fellow in MS after he had completed his neurology residency at Mount Sinai. He was the recipient of an American Academy of Neurology Scholarship and received a Sylvia Lawry Fellowship in clinical research from the National Multiple Sclerosis Society. Dr. Krieger has a clinical practice at the CGDC, and has participated in numerous clinical trials.
Dr. Krieger serves on several advisory boards and steering committees, and is an active member of the American Academy of Neurology (AAN), which awarded him an AB Baker Teaching Recognition Award. He has presented original work at the AAN, the Consortium of Multiple Sclerosis Centers, the Americas Committee for Treatment and Research in Multiple Sclerosis, and the European Committee for Treatment and Research in Multiple Sclerosis. He has written review articles and lectures nationally about MS with an emphasis on emerging therapies. Dr. Krieger proposed the Topographical Model of Multiple Sclerosis: A New Visualization of Disease Course, which was subsequently published in Neurology: Neuroimmunology & Neuroinflammation and was the subject of an article in Scientific American.
-
Clyde E. Markowitz, MD
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania
Clyde E. Markowitz, MD
Associate Professor of Neurology
Department of Neurology
University of Pennsylvania Perelman School of Medicine
Director, Multiple Sclerosis Center
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Clyde E. Markowitz, MD, is director of the Multiple Sclerosis Center at the Hospital of the University of Pennsylvania and associate professor of neurology at the Perelman School of Medicine at the University of Pennsylvania School of Medicine in Philadelphia. He earned his medical degree from Columbia University College of Physicians and Surgeons in New York. He completed his residency, postdoctoral research and clinical fellowship at the Neurological Institute at Columbia University College of Physicians and Surgeons. Dr. Markowitz is involved with numerous clinical trials developing new compounds for the treatment of multiple sclerosis (MS). His research interests include utilization of new MRI techniques to study the pathogenesis and immunology of MS. Dr. Markowitz has held the position of chairman of the Clinical Advisory Committee for the Delaware Valley Chapter of the National Multiple Sclerosis Society. He is the author or co-author of articles in a number of publications, including the Annals of Neurology and Neurology, and serves as an ad hoc reviewer for Multiple Sclerosis, Annals of Neurology, Archives of Neurology, Journal of the Neurological Sciences, Neuro-Rehabilitation, Neural Repair, Journal of Clinical Immunology, and The Consultant. Dr. Markowitz is a member of the American Academy of Neurology and is certified by the National Board of Medical Examiners and the American Board of Psychiatry and Neurology.
-
Aaron E. Miller, MD
Mount Sinai School of Medicine
New York, New York
Aaron E. Miller, MD
Professor of Neurology
Department of Neurology
Icahn School of Medicine at Mount Sinai
Medical Director, Corinne Goldsmith
Dickinson Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, New York
Aaron E. Miller, MD, is a professor of neurology at the Icahn School of Medicine at Mount Sinai and medical director of the Corinne Goldsmith Dickinson Center (CGDC) for Multiple Sclerosis (MS). Dr. Miller received his medical degree from New York University School of Medicine. Following his residency in neurology at the Albert Einstein College of Medicine, he received additional postdoctoral training in neurovirology and immunology at the Johns Hopkins University School of Hygiene and Public Health and at Albert Einstein College of Medicine. Dr. Miller is widely recognized for his preeminence as a clinician. He previously headed the Division of Neurology at Maimonides Medical Center in Brooklyn, New York.
Dr. Miller serves as Chairman of the National Medical Advisory Board of the National Multiple Sclerosis Society (NMSS). He recently completed 15 years as a member of the board of directors of the NMSS and has also recently served for 8 years on the board of the American Academy of Neurology (AAN), including 4 years as secretary. He formerly served as chairman of the Clinical Advisory Board of the National Multiple Sclerosis Society, president of the Consortium of Multiple Sclerosis Centers, and first chairman of the MS section of the AAN. Dr. Miller completed 10 years as editor of Continuum and is currently editor of Continuum Audio. He is the Therapy Section editor for the journal Multiple Sclerosis and Related Disorders. In addition, he serves as a reviewer for several prestigious medical journals including the New England Journal of Medicine, Neurology, and the Multiple Sclerosis Journal.
-
Kottil W. Rammohan, MD
University of Miami Miller School of Medicine
Miami, Florida
Kottil W. Rammohan, MD
Professor, Clinical Neurology
Director, Multiple Sclerosis Center of Excellence
Department of Neurology, University of Miami, Miller School of Medicine
Miami, Florida
Kottil W. Rammohan, MD, is professor of clinical neurology and director of the Multiple Sclerosis Center of Excellence at the University of Miami, Miller School of Medicine. A graduate of Madras Medical College in Chennai, India, Dr. Rammohan completed an internship at Cook County Hospital in Chicago, and a residency in internal medicine and neurology at Ohio State University. He was a fellow and senior clinical associate at the National Institutes of Health where he trained in neurovirology and neuroimmunology. Dr. Rammohan’s primary research is in the pathogenesis and treatment of multiple sclerosis. In particular, in understanding and developing treatments for MS-related fatigue. Dr. Rammohan has served as a member of the National Multiple Sclerosis Society (NMSS) Medical Advisory Board and Clinical Care Committee, and chaired the organization’s National Clinical Advisory Committee. He has been recognized with numerous honors by the NMSS including the Hope Award, Spirit Award, and Outstanding Physician Recognition Award. In addition, he was inducted into the NMSS Hall of Fame and has been listed for several years in the publication Best Doctors in America.
-
Matthew K. Schindler, MD, PhD
University of Pennsylvania
Philadelphia, Pennsylvania
Matthew K. Schindler, MD, PhD
University of Pennsylvania
Philadelphia, Pennsylvania
Matthew K. Schindler, MD, PhD, is an instructor in the Department of Neurology in the MS Division at the Perelman School of Medicine of the University of Pennsylvania in Philadelphia. Dr. Schindler received his MD and PhD degrees in neuroscience, at Wake Forest University School of Medicine. He completed his neurology residency at Yale-New Haven Hospital and the University of Pennsylvania and was a recipient of the National MS Society-American Brain Foundation Clinician Scientist Development Award. With this grant, he completed a neuroimmunology fellowship at the National Institute of Neurological Disorders and Stroke Translational Neuroradiology Section laboratory directed by Dr. Daniel Reich. During his fellowship, Dr. Schindler’s research focused on using advanced imaging techniques including ultra-high field MRI (7T) to probe both common and rare neuroinflammatory diseases. He received an NIH Director’s Merit Award for work related to providing neurological care and clinical research in Liberia following the Ebola epidemic. Dr. Schindler is also a recipient of a KL2 award through the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania. His current research includes studying novel imaging biomarkers that can be used to predict tissue injury with a focus on 7-tesla MRI, differences in outcomes across the age-span in MS, and integrating advanced clinical imaging techniques to improve MS diagnosis and treatment monitoring.